Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

The Trump administration has promised an overhaul of various government agencies. What will happen to the Health Department?

Trump’s pick to lead HHS is facing 175 questions from Elizabeth Warren, skepticism from Mike Pence and delays related to his ...

Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...

The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.

The Supreme Court unanimously upheld a law that threatens to shut down TikTok as soon as Sunday. The justices ruled free ...

The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.

The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price ...

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and stronger." ...